Clinical trial Recruiting at 1 site Interventional Ages 25 to 45

Albumin versus hyaluronic acid scaffolds with concentrated growth factors for non-surgical periodontitis treatment

Official title: Comparison Between the Efficacy of Albumin Versus Hyaluronic Acid Scaffold in Combination With Concentrated Growth Factors as an Adjunct to Non-surgical Treatment of Periodontitis (Randomized Controlled Clinical Trial)

Run by Mansoura University · NCT07081230 · Data updated 2026-11-12

This trial will try whether adding either an albumin-based or a hyaluronic acid scaffold combined with concentrated growth factors to deep cleaning helps adults (25–45) with stage II/III periodontitis heal better.

More Periodontitis trials

Quick facts

Study typeInterventional
Ages25 Years to 45 Years
SexAll
Enrollment30 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah, Mansoura)
StatusRecruiting
StartedJuly 7, 2025
Main results expectedOctober 1, 2025
Study endsNovember 1, 2025
Registry record updatedJuly 23, 2025
Trial IDNCT07081230 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 25–45 with stage II or III periodontitis who are systemically healthy, non-smokers, not pregnant or breastfeeding, and able to comply with study visits.

Probably not a fit

Patients who smoke, have systemic conditions that affect healing, have poor oral hygiene, are pregnant or breastfeeding, or received periodontal treatment in the last six months are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with stage II/III periodontitis will first receive standard non-surgical periodontal therapy and oral hygiene instruction, then be assigned to one of two treatment groups. One group will receive scaling and root planing plus an injection of hyaluronic acid mixed with liquid-phase concentrated growth factors into the periodontal pocket. The other group will receive scaling and root planing plus an albumin-based platelet-rich fibrin (ALB-PRF) preparation derived from the patient’s own blood and combined with concentrated growth factors. Clinical periodontal outcomes will be followed and gingival crevicular fluid will be sampled to measure the concentration and duration of growth factor release.

Why it matters

Potential benefit: If successful, this approach could improve pocket healing after non-surgical treatment, reduce pocket depths, and decrease the need for surgical intervention.

How similar studies have gone: Related work using hyaluronic acid and platelet-rich growth factor concentrates has shown positive effects on periodontal healing, but direct comparisons with albumin-based scaffolds are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
ii) Inclusion Criteria:

* Patients aging from 25-45 years
* Patients with stage II /III periodontitis
* Systemically free iii) Exclusion Criteria:
* Any systemic condition that may impact the study (21)
* Poor oral hygiene
* Pregnant and breastfeeding women
* Smoking patients.
* Patients received periodontal treatment in the last 6 months
* Unable to comply with study protocol

Where it's running

  • Mansoura university Faculty of dentistry
    Al Mansurah, Mansoura, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.